Ian Lowitt - Marex Group Group Director

MRX Stock   29.28  0.13  0.45%   

Director

Ian Lowitt is Group Director of Marex Group plc
Age 60
Address 155 Bishopsgate, London, United Kingdom, EC2M 3TQ
Phone44 20 7655 6000
Webhttps://www.marex.com

Marex Group Management Efficiency

At this time, Marex Group's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.12 in 2024, whereas Return On Equity is likely to drop 0.1 in 2024. At this time, Marex Group's Total Current Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.01 in 2024, whereas Total Assets are likely to drop slightly above 11.7 B in 2024. Marex Group's management efficiency ratios could be used to measure how well Marex Group manages its routine affairs as well as how well it operates its assets and liabilities.
Marex Group plc has 3.17 B in debt with debt to equity (D/E) ratio of 0.72, which is OK given its current industry classification. Marex Group plc has a current ratio of 2.68, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Marex to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Todd EsqHoulihan Lokey
61
Simon RobertsonEvercore Partners
79
James CostosPJT Partners
58
Stuart ReeseJefferies Financial Group
63
Jane MendilloLazard
61
Ellen FutterEvercore Partners
70
Robert JoyalJefferies Financial Group
74
Dennis HerschPJT Partners
72
Jacqueline KosecoffHoulihan Lokey
71
Sylvia JayLazard
73
Robert SchriesheimHoulihan Lokey
60
Robert MillardEvercore Partners
70
Hideto NishitaniHoulihan Lokey
58
Steven HeyerLazard
66
William WheelerEvercore Partners
58
Gail HarrisEvercore Partners
67
Kenneth WhitneyPJT Partners
63
Thomas RyanPJT Partners
68
David YingEvercore Partners
69
Andrew AlperLazard
62
Michael OKaneJefferies Financial Group
75
Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada. Marex Group plc (MRX) is traded on NASDAQ Exchange in USA. It is located in 155 Bishopsgate, London, United Kingdom, EC2M 3TQ and employs 1,063 people. Marex Group is listed under Investment Banking & Brokerage category by Fama And French industry classification.

Management Performance

Marex Group plc Leadership Team

Elected by the shareholders, the Marex Group's board of directors comprises two types of representatives: Marex Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marex. The board's role is to monitor Marex Group's management team and ensure that shareholders' interests are well served. Marex Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marex Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mahesh Vittal, Chief Americas
Harvey Moses, Head Development
Ann Bull, Group Compliance
Graham Francis, Group Officer
Robert Coates, Head Relations
Liz Barrett, Group HR
Michael Dugan, Chief Officer
Crispin Irvin, CFO Director
Ian Lowitt, Group Director
Nick Jones, Head Legal
Paolo Tonucci, Chief Markets
Matthew France, Metals Sales
Simon Born, President

Marex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Marex Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Marex Stock Analysis

When running Marex Group's price analysis, check to measure Marex Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marex Group is operating at the current time. Most of Marex Group's value examination focuses on studying past and present price action to predict the probability of Marex Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marex Group's price. Additionally, you may evaluate how the addition of Marex Group to your portfolios can decrease your overall portfolio volatility.